Chromosomal changes in ovarian cancer

Current Diagnostic Pathology

Volumn 9, Issue 5, 2003, Pages 328-332

  Mayr, D ^a   Diebold, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Carcinoma; Comparative genomic hybridization (CGH); Fluorescence in situ hybridization (FISH); Granulosa cell tumour; Immunohistochemistry; Ovary

Indexed keywords

CYCLIN D1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; TYROSINE KINASE RECEPTOR;

APOPTOSIS; CELL PROLIFERATION; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 18; CHROMOSOME 20Q; CHROMOSOME 3Q; CHROMOSOME 4; CHROMOSOME 8Q; CHROMOSOME ABERRATION; GENETIC VARIABILITY; GRANULOSA CELL TUMOR; HUMAN; MOLECULAR GENETICS; MONOSOMY; OVARY CANCER; PHENOTYPE; REVIEW; TRISOMY; TRISOMY 12; TRISOMY 14; TUMOR GROWTH; X CHROMOSOME;

EID: 0242391815     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(03)00050-4     Document Type: Review

References (29)

1. Mayr D, Diebold J. Grading of ovarian carcinomas. Int J Gynecol Pathol 2000; 19: 348-353.
2. Mayr D, Pannekamp U, Baretton G B et al. Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas. Pathol Res Pract 2000; 196: 469-475.
3. Diebold J. Phänotyp - Genotyp - Korrelation bei Ovarialneoplasien. Verh Dtsch Ges Path 2001; 85: 153-160.
4. Suzuki S, Moore I I D, Ginzinger D et al. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res 2000; 60: 5382-5385.
5. Tumorregister München, Jahresbericht 1999. Schwerpunkt: Gynäkologische Tumoren. Zuckschwerdt Verlag, Germering/München, 2000.
6. Jimbo J, Hitomi Y, Yoshikawa H et al. Clonality analysis of bilateral ovarian endometriod cysts. Fertil Steril 1999; 72: 1142-1143.
7. Corner G W Jr, Hu C Y, Hertig A T. Ovarian carcinoma arising in endometrioisis. Am J Obstet Gynecol 1950; 59: 760-774.
8. Scully R E, Richardson G S, Barlow J F. The development of malignancy in endometriosis. Clin Obstet Gynecol 1966; 381-414.
9. Jiang X, Hitchcock A, Bryan E J et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at cancidate ovarian tumor suppressor gene loci. Cancer Res 1996; 56: 3534-3539.
10. Yano T, Jimbo H, Yoshikawa H, Tsusumi O, Taketani Y. Molecular analysis of clonality in ovarian endometrial cysts. Gynecol Obstet Invest 1999; 47 (Suppl 1): 41-46.
11. Mayr D, Amann G, Siefert C, Diebold J, Anderegg B. Does endometriosis really have premalignant potential? A clonal analysis of laser-microdissected tissue. FASEB J 2003; 10: 1096.
12. Kiechle M, Jacobson A, Schwarz-Boeger U, Hederich J, Pfisterer J, Arnold N. Comparative genomic hybridisation detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentation. Cancer 2001; 91: 534-540.
13. Suzuki S, Moore D H, Ginzinger D G et al. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res 2000; 60: 5382-5385.
14. Tanner M M, Grenman S, Koul A et al. Frequent amplification of chromosomal region 20q12-q13 In ovarlan cancer. Clin Cancer Res 2000; 6: 1833-1839.
15. Tapper J, Bützow R, Wahlström T, Seppälä M, Knuutila S. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas. Br J Cancer 1997; 75: 1782-1787.
16. Anand N, Merthy S, Amann G et al. Protein elongation factor EEFIA2 is a putative oncogene in ovarian cancer. Nat Genet 2002; 31: 301-305
17. Jazaeri A A, Lu K, Schmandt R et al. Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma. Mol Carcinog 2003; 36: 53-59.
18. Peiro G, Mayr D, Hillemanns P, Löhrs U, Diebold J. Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridisation (CISH). Correlation with FISH, HER/2neu, p53 and ki67 protein expression, and outcome. Mod Pathol, in press, 2003.
19. Sonoda G, Palazzo J, du Manoir S et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24 and 20q13 in human carcinomas. Gene Chromosome Cancer 1997; 20: 320-328.
20. Sherr C J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000; 60: 3689-3695.
21. Mayr D, Kaltz-Wittmer C, Arbogast S, Amann G, Aust D E, Diebold J. Characteristic pattern of genetic aberrations in ovarian granulosa cell tumors. Mod Pathol 2001; 15: 951-957.
22. Halperin D, Visscher D W, Wallis T, Lawrence W D. Evaluation of chromosome 12 copy number in ovarian granulosa cell tumours using interphase cytogenetics. Int Gynecol Pathol 1995; 14: 319-323.
23. Gorski G K, McMorrow L E, Blumstein L, Faasse D, Donaldson M H. Trisomy 14 in two cases of granulosa cell tumor of the ovary. Cancer Genet Cytogenet 1992; 60: 202-205.
24. Suh K S, Silverberg S G, Rhame J G, Wilkinson D S. Granulosa cell tumor of the ovary. Arch Pathol Lab Med 1990; 114: 496-501.
25. Persons D L, Hartmann L C, Herath J F, Keeney G L, Jenkins R B. Fluorescence in situ hybridization analysis of trismoy 12 in ovarian tumors. Am J Clin Pathol 1994; 102: 775-779.
26. Shashi V, Golden W L, von Kap-Herr C, Andersen W A, Gaffey M J. Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors. Gynecol Oncol 1994; 55: 349-354.
27. Cin P D, Qi H, Paulwels P, Backx C, van den Berghe H. Monosomy 22 in a forbothecoma. Cancer Genet Cytogenet 1997; 99: 129-131.
28. Speleman F, Dermaut B, de Potter C R et al. Monosomy 22 in a mixed germ cell-sex cord-stromal tumor of the ovary. Genes Chromosomes Cancer 1997; 19: 192-194.
29. Van den Berghe I, Dal Cin P, de Groef K, Michielssen P, van den Berghe H. Monosomy 22 and trisomy 14 may be early events in the tumorigenesis of adult granulosa cell tumor. Cancer Genet Cytogenet 1999; 112: 46-48.